Investing.com - Eton Pharmaceuticals (NASDAQ:ETON) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Eton Pharmaceuticals announced earnings per share of $-0.120 on revenue of $3.22M. Analysts polled by Investing.com anticipated EPS of $-0.180 on revenue of $3M.
Eton Pharmaceuticals shares are down 28.35% from the beginning of the year, still down 52.01% from its 52 week high of $5.23 set on November 15, 2021.
Eton Pharmaceuticals follows other major Healthcare sector earnings this month
Eton Pharmaceuticals's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar